ASX News
Neurizon NUZ-001 OLE study demonstrates long-term safety, efficacy signals
HotCopper sat down with Neurizon Therapeutics MD Michael Thurn to discuss the clinical-stage biotech company's latest NUZ-001 OLE study.
Market Cap $107.0B
!
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| WES | Anti semitism at Wesfarmers | 16:29 | 440 | 126K | |||
|
|||||||
| WES | Ann: Advance notice - 2025 Full-year results | 12:58 | 22 | 7.0K | |||
|
|||||||
| WES | Are Jews welcome at the WES AGM? | 09/08/25 | 240 | 72K | |||
|
|||||||
| WES | Ann: Completion of sale of Coregas | 01/07/25 | 0 | 517 | |||
|
|||||||
| WES | Ann: BWP internalisation and reset of Bunnings leases | 27/06/25 | 0 | 381 | |||
|
|||||||
| WES | Ann: BWP: Meeting Booklet | 27/06/25 | 0 | 363 | |||
|
|||||||
| WES | Ann: BWP: BWP Investor Briefing Presentation | 27/06/25 | 0 | 340 | |||
|
|||||||
| WES | Ann: BWP: BWP Internalisation,Bunnings Lease Reset,Cap Investment | 27/06/25 | 0 | 339 | |||
|
|||||||
See All Discussions
Timeline
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
| View More | |||||
Latest Articles
 (20min delay)
|
|||||
|
Last
$94.76 |
Change
2.290(2.48%) |
Mkt cap ! $107.0B | |||
| Open | High | Low | Value | Volume |
| $93.37 | $94.76 | $92.42 | $228.7M | 2.430M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30 | $94.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $94.76 | 8124 | 3 |
View Market Depth
| Last trade - 16.11pm 21/08/2025 (20 minute delay) ? |
|
|||||
|
Last
$94.34 |
Change
2.290 ( 2.23 %) |
||||
| Open | High | Low | Volume | ||
| $93.18 | $94.47 | $92.76 | 487341 | ||
| Last updated 15.59pm 21/08/2025 ? | |||||
| WES (ASX) Chart |
